Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Endotronix-IDE

More Like This

PR Newswire associated0

Endotronix Presents Positive PROACTIVE-HF Clinical Trial Results for its Cordella Pulmonary Artery Sensor

PR Newswire associated0

Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure

PR Newswire associated0

ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM

PR Newswire associated0

Endotronix Submits PMA Application for its Cordella Pulmonary Artery Sensor System

PR Newswire associated0

CardiaCare Completes Seed Extension Raise to Support Clinical Pilot Studies

Impulse Dynamics Completes $136M Financing Round

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease